2-aminoadipic acid has been researched along with Leukemia L 1210 in 1 studies
2-Aminoadipic Acid: A metabolite in the principal biochemical pathway of lysine. It antagonizes neuroexcitatory activity modulated by the glutamate receptor, N-METHYL-D-ASPARTATE; (NMDA).
2-aminoadipic acid : An alpha-amino acid that is adipic acid bearing a single amino substituent at position 2. An intermediate in the formation of lysine.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bisset, GM | 1 |
| Bavetsias, V | 1 |
| Thornton, TJ | 1 |
| Pawelczak, K | 1 |
| Calvert, AH | 1 |
| Hughes, LR | 1 |
| Jackman, AL | 1 |
1 other study available for 2-aminoadipic acid and Leukemia L 1210
| Article | Year |
|---|---|
The synthesis and thymidylate synthase inhibitory activity of L-gamma-L-linked dipeptide and L-gamma-amide analogues of 2-desamino-2-methyl-N10-propargyl-5,8-dideazafolic acid (ICI 198583).
Topics: 2-Aminoadipic Acid; Animals; Binding Sites; Cell Division; Dipeptides; Drug Stability; Folic Acid; G | 1994 |